Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-25-100084
Filing Date
2025-10-17
Accepted
2025-10-17 20:33:44
Documents
1
Period of Report
2024-10-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1548
  Complete submission text file 0001213900-25-100084.txt   2934
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Issuer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 114 EAST 4TH AVENUE, SUITE 800 VANCOUVER A1 V5T 1G4
Business Address
Klompas Neil A (Reporting) CIK: 0001761857 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39685 | Film No.: 251402170